|
1
|
Ghoncheh M, Pournamdar Z and Salehiniya H:
Incidence and mortality and epidemiology of breast cancer in the
world. Asian Pac J Cancer Prev. 17:43–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Santa-Maria CA and Gradishar WJ: Changing
treatment paradigms in metastatic breast cancer: Lessons learned.
JAMA Oncol. 1(528–534): 5492015.
|
|
3
|
Hu G, Chong RA, Yang Q, Wei Y, Blanco MA,
Li F, Reiss M, Au JL, Haffty BG and Kang Y: MTDH activation by 8q22
genomic gain promotes chemoresistance and metastasis of
poor-prognosis breast cancer. Cancer Cell. 15:9–20. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moses H and Barcellos-Hoff MH: TGF-beta
biology in mammary development and breast cancer. Cold Spring Harb
Perspect Biol. 3:a0032772011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Silberstein GB and Daniel CW: Reversible
inhibition of mammary gland growth by transforming growth
factor-beta. Science. 237:291–293. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Muraoka RS, Dumont N, Ritter CA, Dugger
TC, Brantley DM, Chen J, Easterly E, Roebuck LR, Ryan S, Gotwals
PJ, et al: Blockade of TGF-beta inhibits mammary tumor cell
viability, migration, and metastases. J Clin Invest. 109:1551–1559.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie L, Law BK, Aakre ME, Edgerton M, Shyr
Y, Bhowmick NA and Moses HL: Transforming growth factor
beta-regulated gene expression in a mouse mammary gland epithelial
cell line. Breast Cancer Res. 5:R187–R198. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu Y, Wang Y, Ren X, Tsuyada A, Li A, Liu
LJ and Wang SE: Context-dependent bidirectional regulation of the
MutS homolog 2 by transforming growth factor β contributes to
chemoresistance in breast cancer cells. Mol Cancer Res.
8:1633–1642. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Y, Jia L, Liu C, Gong Y, Ren D, Wang N,
Zhang X and Zhao Y: Axl as a downstream effector of TGF-β1 via
PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and
chemoresistance in breast carcinoma. Tumour Biol. 36:1115–1127.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wieser R: The transforming growth
factor-beta signaling pathway in tumorigenesis. Curr Opin Oncol.
13:70–77. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davis BN, Hilyard AC, Lagna G and Hata A:
SMAD proteins control DROSHA-mediated microRNA maturation. Nature.
454:56–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lakhani SR, Ellis IO, Schnitt SJ, Tan PJ
and van de Vijver MJ: WHO Classification of Tumours of the Breast.
Fourth. IARC; Lyon, France: 2012
|
|
17
|
Zhang Y, Wang SX, Ma JW, Li HY, Ye JC, Xie
SM, Du B and Zhong XY: EGCG inhibits properties of glioma stem-like
cells and synergizes with temozolomide through downregulation of
P-glycoprotein inhibition. J Neurooncol. 121:41–52. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao X, Liao X, Qiu S, Liu Z, Du B and Xu
S: Synthesis, cytotoxicity and apoptosis induction in human tumor
cells by galaxamide and its analogues [corrected]. Mar Drugs.
12:4521–4538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qian B, Katsaros D, Lu L, Preti M, Durando
A, Arisio R, Mu L and Yu H: High miR-21 expression in breast cancer
associated with poor disease-free survival in early stage disease
and high TGF-beta1. Breast Cancer Res Treat. 117:131–140. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du B, Yang ZY, Zhong XY, Fang M, Yan YR,
Qi GL, Pan YL and Zhou XL: Metastasis-associated protein 1 induces
VEGF-C and facilitates lymphangiogenesis in colorectal cancer.
World J Gastroenterol. 17:1219–1226. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Padua D and Massagué J: Roles of TGFbeta
in metastasis. Cell Res. 19:89–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giunti L, da Ros M, Vinci S, Gelmini S,
Iorio AL, Buccoliero AM, Cardellicchio S, Castiglione F, Genitori
L, de Martino M, et al: Anti-miR21 oligonucleotide enhances
chemosensitivity of T98G cell line to doxorubicin by inducing
apoptosis. Am J Cancer Res. 5:231–242. 2014.PubMed/NCBI
|
|
23
|
Kitamura K, Seike M, Okano T, Matsuda K,
Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K and Gemma A:
MiR-134/487b/655 cluster regulates TGF-β-induced
epithelial-mesenchymal transition and drug resistance to gefitinib
by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther.
13:444–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Singha PK, Pandeswara S, Geng H, Lan R,
Venkatachalam MA and Saikumar P: TGF-β induced TMEPAI/PMEPA1
inhibits canonical Smad signaling through R-Smad sequestration and
promotes non-canonical PI3K/Akt signaling by reducing PTEN in
triple negative breast cancer. Genes Cancer. 5:320–336.
2014.PubMed/NCBI
|
|
25
|
Chung AC, Dong Y, Yang W, Zhong X, Li R
and Lan HY: Smad7 suppresses renal fibrosis via altering expression
of TGF-β/Smad3-regulated microRNAs. Mol Ther. 21:388–398. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Noetel A, Kwiecinski M, Elfimova N, Huang
J and Odenthal M: microRNA are central players in anti- and
profibrotic gene regulation during liver fibrosis. Front Physiol.
3:492012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang H, Zhang C, Ban T, Liu Y, Mei L,
Piao X, Zhao D, Lu Y, Chu W and Yang B: A novel reciprocal loop
between microRNA-21 and TGFβRIII is involved in cardiac fibrosis.
Int J Biochem Cell Biol. 44:2152–2160. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Katsuno Y, Hanyu A, Kanda H, Ishikawa Y,
Akiyama F, Iwase T, Ogata E, Ehata S, Miyazono K and Imamura T:
Bone morphogenetic protein signaling enhances invasion and bone
metastasis of breast cancer cells through Smad pathway. Oncogene.
27:6322–6333. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Imamura T, Hikita A and Inoue Y: The roles
of TGF-β signaling in carcinogenesis and breast cancer metastasis.
Breast Cancer. 19:118–124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H, Wu H, Zheng J, Yu P, Xu L, Jiang
P, Gao J, Wang H and Zhang Y: Transforming growth factor β1 signal
is crucial for dedifferentiation of cancer cells to cancer stem
cells in osteosarcoma. Stem Cells. 31:433–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Pan T, Zhong X and Cheng C:
Nicotine upregulates microRNA-21 and promotes TGF-β-dependent
epithelial-mesenchymal transition of esophageal cancer cells.
Tumour Biol. 35:7063–7072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gong C, Yao Y, Wang Y, Liu B, Wu W, Chen
J, Su F, Yao H and Song E: Up-regulation of miR-21 mediates
resistance to trastuzumab therapy for breast cancer. J Biol Chem.
286:19127–19137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cantley LC and Neel BG: New insights into
tumor suppression: PTEN suppresses tumor formation by restraining
the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA.
96:4240–4245. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stambolic V, MacPherson D, Sas D, Lin Y,
Snow B, Jang Y, Benchimol S and Mak TW: Regulation of PTEN
transcription by p53. Mol Cell. 8:317–325. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu ZH, Tao ZH, Zhang J, Li T, Ni C, Xie J,
Zhang JF and Hu XC: MiRNA-21 induces epithelial to mesenchymal
transition and gemcitabine resistance via the PTEN/AKT pathway in
breast cancer. Tumour Biol. 37:7245–7254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dey N, Ghosh-Choudhury N, Kasinath BS and
Choudhury GG: TGFβ-stimulated microRNA-21 utilizes PTEN to
orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and
matrix expansion. PLoS One. 7:e423162012. View Article : Google Scholar : PubMed/NCBI
|
